IP Library Granted Patent US 11,046,980
Granted Patent B2
US 11,046,980 · App. 16/404,241 · Granted Jun 29, 2021

Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid

Inventors: Jun Ogawa (Kyoto, JP); Shigenobu Kishino (Kyoto, JP); Teruo Kawada (Kyoto, JP); Nobuyuki Takahashi (Kyoto, JP); Tsuyoshi Goto (Kyoto, JP); Yasunori Yonejima (Muko, JP)
Assignees: KYOTO UNIVERSITY; Noster, Inc.
C12P7/6409C07C59/42C12N9/0006C12N9/0069C12P7/42C12P7/6427
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,046,980
App. No.
16/404,241
Granted
Jun 29, 2021
Kind
B2
Abstract

The present invention provides production of hydroxylated fatty acid by a hydration reaction using a novel enzyme derived from Lactobacillus and using fatty acid as a substrate, and further, a production method of oxo fatty acid by an enzyme reaction or chemical oxidation reaction using the hydroxylated fatty acid as a substrate. In addition, a valuable novel rare fatty acid obtained by such production method is also provided.

Claims (8)

1. 14-Hydroxy-cis-4,cis-7,cis-10,cis-16,cis-19-docosapentaenoic acid.

2. A method of producing 14-hydroxy-cis-4,cis-7,cis-10,cis-16,cis-19-docosapentaenoic acid, comprising incubating under suitable conditions cis-4,cis-7,cis-10,cis-13,cis-16,cis-19-docosahexaenoic acid with a hydratase of any of the following (a)-(c):

(a) the protein consisting of the amino acid sequence shown in SEQ ID NO: 2,

(b) a protein comprising an amino acid sequence wherein one to twenty amino acids in the amino acid sequence shown in SEQ ID NO: 2 are deleted and/or substituted and/or inserted and/or added, and having an enzyme activity that catalyzes a hydration reaction, and

(c) a protein encoded by a nucleotide sequence that hybridizes to a nucleic acid consisting of a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 under conditions comprising a wash in 0.1×SSC, 0.1% SDS at 68° C., and having an enzyme activity that catalyzes a hydration reaction.

3. A method of producing 14-hydroxy-cis-4,cis-7,cis-10,cis-16,cis-19-docosapentaenoic acid according to claim 2 , wherein the hydratase is the protein consisting of the amino acid sequence shown in SEQ ID NO: 2.

4. A method of producing 14-hydroxy-cis-4,cis-7,cis-10,cis-16,cis-19-docosapentaenoic acid according to claim 2 , wherein the hydratase is a protein comprising an amino acid sequence wherein one to twenty amino acids in the amino acid sequence shown in SEQ ID NO: 2 are deleted and/or substituted and/or inserted and/or added, and having an enzyme activity that catalyzes a hydration reaction.

5. A method of producing 14-hydroxy-cis-4,cis-7,cis-10,cis-16,cis-19-docosapentaenoic acid according to claim 2 , wherein the hydratase is a protein encoded by a nucleotide sequence that hybridizes to a nucleic acid consisting of a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 under conditions comprising a wash in 0.1×SSC, 0.1% SDS at 68° C., and having an enzyme activity that catalyzes a hydration reaction.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE PROPERTY TYPE FROM APPLICATION NUMBER TO PATENT NUMBER FOR 10952983 AND 10975397 PREVIOUSLY RECORDED AT REEL: 68851 FRAME: 663. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 18, 2024
From: KYOTO UNIVERSITY
To: NOSTER INC.
Reel/Frame 069207/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2024
From: OGAWA, JUN; KISHINO, SHIGENOBU; KAWADA, TERUO; TAKAHASHI, NOBUYUKI; GOTO, TSUYOSHI; YONEJIMA, YASUNORI
To: KYOTO UNIVERSITY; NITTO PHARMACEUTICAL INDUSTRIES, LTD.
Reel/Frame 068931/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2024
From: KYOTO UNIVERSITY
To: NOSTER INC.
Reel/Frame 068851/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2021
From: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
To: NOSTER INC.
Reel/Frame 055920/0263 →
Priority Claims (1)
JP 2014-011855 · Jan 24, 2014 · national
Continuity (2)
Division 15113604
Related Publication 20190256876A1 · Aug 22, 2019